We have had great success in building a life sciences patent litigation team with the depth and range to handle our clients’ ...

Melinda R. Roberts, a Member at Mintz, is a patent litigator who represents pharmaceutical and life sciences companies in ...

Mintz represented Delta Associated Investigations, a tech-enabled national provider of investigative and claims support ...

The 2027 business immigration outlook for employers combines new restrictions with legal uncertainty. Automatic Employment Authorization Document (EAD) extensions are ending and visa processing is ...

Mitch Frazer, Managing Partner of Mintz's Toronto office, has received an honorary Doctor of Laws degree from Western ...

Mintz represented the US Department of Energy in the closing of two separate loans totaling up to approximately $5.1 billion ...

Benchmark Litigation has recognized 23 Mintz attorneys in its 2027 guide to the leading litigation firms and lawyers in the United States. Mintz was also named Highly Recommended in Massachusetts and ...

Michael Renaud, Chair of Mintz’s Intellectual Property Division, has been named to IAM Global Leaders 2027, a guide ...

On October 1, the Health Resources and Services Administration (HRSA) published 10 approved rebate plans covering 18 Medicare-negotiated drugs, setting a January 1, 2027, start. As we warned in The ...

On September 18, 2026, President Trump issued a proclamation that extends through September 21, 2027 a $100,000 fee for H-1B petitions that are filed as consular petitions or are only approvable for ...

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies ...